Concepedia

Keita Fukao

KF

Statistics

Publications

8

Citations

338

H-Index

8

Active since

2004

Affiliations

Shionogi (Japan)(Current)

Hokkaido University

Keita Fukao is an author at Shionogi (Japan) specializing in antiviral agents, pharmacology, and antiviral pharmacology.

Publications per year

2004–2023

8

Publications

8

Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection

Keita Fukao, Takeshi Noshi, Atsuko Yamamoto et al. · Journal of Antimicrobial Chemotherapy · 2018 · 104 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Expression of the chicken peroxisome proliferator-activated receptor-γ gene is influenced by aging, nutrition, and agonist administration

Kei Sato, Keita Fukao, Yoshinori Seki et al. · Poultry Science · 2004 · 63 citations · Full text

Life Sciences, Physiology, Poultry Science +15

Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models

Keita Fukao, Yoshinori Ando, Takeshi Noshi et al. · PLoS ONE · 2019 · 47 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2<i>in vitro</i>and<i>in vivo</i>

Takayuki Kuroda, Haruaki Nobori, Keita Fukao et al. · Journal of Antimicrobial Chemotherapy · 2023 · 45 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model

Haruaki Nobori, Keita Fukao, Takayuki Kuroda et al. · Journal of Antimicrobial Chemotherapy · 2022 · 33 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

1–5 of 8